Showing 281-290 of 3380 results for "".
Expert Panel Consensus on Uniform Nomenclature and Diagnosis for Neuropathic Pruritus
https://practicaldermatology.com/issues/june-2024/expert-panel-consensus-on-uniform-nomenclature-and-diagnosis-for-neuropathic-pruritus/26549/Dr. Peter Lio and colleagues look at a 2023 article working to establish a consensus on uniform nomenclature and diagnosis for neuropathic pruritis.JAK Inhibitors Make the Cut for Alopecia Areata
https://practicaldermatology.com/topics/hair-nails/jak-inhibitors-make-the-cut-for-alopecia-areata/23935/JAK inhibitor approvals increase the opportunity for patients with alopecia areata to experience “life-changing” results.CSF After Dark
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/csf-after-dark/20386/ICYMI: Updates from behind the scenes at the 10th Annual Cosmetic Surgery Forum.Sneak Peek: CSF Returns to Nashville
https://practicaldermatology.com/conferences/cosmetic-surgery-forum-2021/sneak-peek-csf-returns-to-nashville/23617/Next month’s live meeting covers a range of hot topics in dermatology.A Case Study in Selling a Dermatology Practice
https://practicaldermatology.com/topics/practice-management/a-case-study-in-selling-a-dermatology-practice/27166/Clint Bundy, an M&A advisor specializing in physician practices, talks with Dr. Alison Moon, a distinguished physician and former owner of First Coast Dermatology, about the process of the sale of her practice.How NEMLUVIO® Works
https://practicaldermatology.com/programs/nemluvio-peer-network/how-nemluvio-works/37226/Learn how NEMLUVIO® works to directly block IL-31RA from Dr Peter Lio, a leading dermatologist, with extensive experience in treating neuroimmune skin diseases.Understanding the MOA of NEMLUVIO®: Targeting IL-31 Signaling in Neuroimmune Skin Diseases
https://practicaldermatology.com/programs/nemluvio-peer-network/understanding-the-moa-of-nemluvio-targeting-il-31-signaling-in-neuroimmune-skin-diseases/37128/Watch Dr Peter Lio as he explains the role of IL-31, a key neuroimmune cytokine, in AD and PN and provides an in depth overview of the mechanism of action for NEMLUVIO®.Getting to Know Juvéderm Volbella XC
https://practicaldermatology.com/topics/practice-management/getting-to-know-juvderm-volbella-xc/20864/CSF faculty members share Volbella pearls.How Do You Treat Alopecia Areata of the Eyebrows?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/how-do-you-treat-alopecia-areata-of-the-eyebrows/19822/Intralesional corticosteroids are a key part of treatment. Dr. Friedman discusses safe use, as well as additional treatment strategies.The Future of Laser and Device-based Procedures
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-future-of-laser-and-device-based-procedures/19345/New technologies and economic pressures on clinicians ensure a promising future for aesthetic laser treatment, according to Dr. Eric Bernstein.